Ind-Swift Ltd's Q3FY25 Quarter Results
- 12 Feb 2025
Result Summary
- Ind-Swift Ltd reported a 12.9% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Dec (Q3FY25). On a year-on-year (YoY) basis, it witnessed a growth of 16.7%.
- Its expenses for the quarter were down by 6.3% QoQ and up 6.8% YoY.
- The net profit decreased 233.8% QoQ and decreased 63.3% YoY.
- The earnings per share (EPS) of Ind-Swift Ltd declined at 1 during Q3FY25.
Financial Statments for Q3FY25
| (₹ crores) | Q3FY25 | Q2FY25 | Q3FY24 | QoQ (%) | YoY (%) |
|---|---|---|---|---|---|
Total Income | 122.78 | 140.97 | 105.18 | -12.9% | 16.7% |
Total Expenses | 128.28 | 136.86 | 120.15 | -6.3% | 6.8% |
Profit Before Tax | -5.50 | 4.11 | -14.97 | -233.8% | -63.3% |
Tax | 0.00 | 0.00 | 0.00 | - | - |
Profit After Tax | -5.50 | 4.11 | -14.97 | -233.8% | -63.3% |
Earnings Per Share | -1.00 | 0.80 | -2.80 | -225.0% | -64.3% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Company Overview
Ind-Swift Ltd is a company engaged in the pharmaceutical industry, known for manufacturing and marketing a wide range of pharmaceutical products. The company operates primarily in the generic drug segment, focusing on providing affordable medication solutions. Ind-Swift Ltd has been active in both domestic and international markets, catering to a diverse clientele. The company has also been involved in research and development activities to expand its product portfolio. However, specific recent developments or strategic initiatives during the current quarter are not available in the provided data.
Revenue
For the third quarter of the fiscal year 2025 (Q3FY25), Ind-Swift Ltd reported a total income of ₹122.78 crores. This represents a decrease when compared to the previous quarter (Q2FY25), where the total income was ₹140.97 crores, indicating a quarter-over-quarter (QoQ) decline of 12.9%. However, compared to the same quarter in the previous year (Q3FY24), where the total income was ₹105.18 crores, there is a year-over-year (YoY) increase of 16.7%. This shows variability in the company's revenue performance over different periods.
Profitability
The company's profitability metrics for Q3FY25 reveal a profit before tax (PBT) of -₹5.50 crores, indicating a loss for the quarter. This is a significant decrease from a profit of ₹4.11 crores reported in Q2FY25, reflecting a QoQ change of -233.8%. However, compared to a loss of ₹14.97 crores in Q3FY24, there is a YoY improvement of 63.3%. The profit after tax (PAT) aligns with the PBT figures, as the tax paid is recorded as ₹0.00 crores for all the periods provided. The earnings per share (EPS) also reflect this trend, with a figure of -₹1.00 in Q3FY25 compared to ₹0.80 in Q2FY25 and -₹2.80 in Q3FY24, showing both QoQ and YoY changes of -225.0% and 64.3%, respectively.
Operating Metrics
In terms of operating metrics, the total expenses for Q3FY25 were ₹128.28 crores, which is a decrease from ₹136.86 crores in Q2FY25, marking a QoQ reduction of 6.3%. Compared to Q3FY24, where the total expenses were ₹120.15 crores, there is a YoY increase of 6.8%. The reduction in QoQ expenses did not translate into profitability for the quarter due to the decline in total income. The consistent lack of tax expenses across these periods suggests a focus on managing operational costs and investments in areas potentially impacting tax liabilities. However, specific operational metrics such as production volumes, cost per unit, or inventory levels are not provided in the available data.
